L’Oréal has acquired a majority stake in UK’s Medik8 to enhance its skincare market presence. The deal involves Inflexion as a minority shareholder, with the stake's cost undisclosed but estimated at €1bn. L’Oréal aims to leverage the growing demand for science-driven skincare, with Medik8 complementing its existing portfolio. The Dermatological Beauty Division has seen significant revenue growth, and L’Oréal continues to expand its offerings through various acquisitions. Teljes cikk (Euronews.com)